Japan's Kissei and JCR link for Aranesp biosimilar
This article was originally published in Scrip
Executive Summary
Kissei Pharmaceutical and JCR Pharmaceuticals have built on an existing alliance by signing a new collaborative R&D agreement for a biosimilar version of darbepoietin alfa.